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Vibrio cholerae is an aerobic, sucrose fermentative Gram-negative bacterium that
generally prevails in the environment. Pathogenic V. cholerae is well-known as causative
agent of acute diarrhea. Apart from enteric infections, V. cholerae may also cause
other diseases. However, their role in causing extraintestinal infections is not fully
known as it needs proper identification and evaluation. Four cases of extraintestinal
infections due to V. cholerae non-O1/non-O139 have been investigated. The isolates
were screened for phenotypic and genetic characteristics with reference to their major
virulence genes. Serologically distinct isolates harbored rtx, msh, and hly but lacked
enteric toxin encoding genes that are generally present in toxigenic V. cholerae. Timely
detection of this organism can prevent fatalities in hospital settings. The underlying
virulence potential of V. cholerae needs appropriate testing and intervention.
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INTRODUCTION
The Gram-negative bacillus Vibrio cholerae is classiﬁed into serogroups based on the somatic “O”
surface antigen. Broadly, they are divided into O1, O139, and non-O1/non-O139 serogroups (Sack
et al., 2004). V. cholerae O1 is generally regarded as a non-invasive enteric organism associated
with gastroenteritis of varying severity (Sack et al., 2004). The serogroups O1 and O139 are
associated with cholera infection, whereas the non-O1/non-O139 serogroups are commonly found
as an autochthonous microbe in coastal and marine environments, which may cause cholera-like
diarrhea. Several major virulence factors such as cholera toxin (CT), responsible for excess ﬂuid
secretion and the toxin coregulated pilus (TCP), involved in intestinal colonization have been
reported. V. cholerae non-O1/non-O139 serogroups generally lack CT and TCP causes infection
through other virulence factors including the heat-stable toxin (NAG-ST) and hemolysin (Hly) a
type III secretion system (TTSS;Dziejman et al., 2005; Bag et al., 2008) and cholix toxin (Chx; Purdy
et al., 2010). Several of these virulence factors have been documented in clinical and environmental
V. cholerae non-O1/non-O139 isolates from Italy (Ottaviani et al., 2009), Mexico (Lizárraga-
Partida and Quilici, 2009), USA (Purdy et al., 2010; Ceccarelli et al., 2015), China (Luo et al., 2013),
and India (Rajpara et al., 2013).
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Although biochemically indistinguishable from enteric
infection causing V. cholerae O1/O139, the non-O1/non-O139
serogroups have been associated with extraintestinal infection
including septicemia, wound infection, peritonitis, skin infection,
cellulitis, necrotizing fasciitis, endophthalmitis, ear infection,
cholecystitis, and meningitis (CDC, 2014; Chen et al., 2015; Hao
et al., 2015). Here we report one case of urinary tract infection
(UTI) and three cases of septicemia associated with diverse
manifestations caused by various serogroups of V. cholerae
non-O1/non-O139.
CASE 1
A 60-years-old female came to Manipal Hospital, Bangalore for
an emergency treatment with a history of three episodes of
hematuria 3 days earlier. She was suﬀering from diabetes and
hypertension for the last couple of years and was under treatment.
She gave a history of UTI after a long train journey and was
asymptomatic for 3 days after which she had hematuria with
dysuria. She had no previous history of UTI, blood transfusion,
alcohol intake or drug abuse. She also had no recent history
of diarrhea or fever. Ultrasound of abdomen did not show
any abnormality. At the hospital, the preliminary diagnosis was
suspected UTI and urine was collected for culture and empirical
oﬂoxacin 200 mg was prescribed. Urine analysis revealed 10–15
pus cells per high power ﬁeld and there was no blood, glucose
or protein. Urine culture was done on 5% sheep blood agar and
MacConkey agar. After 24 h of incubation, bacterial growth of
105 cfu/ml was detected on blood agar as identical β-hemolytic
colonies. Three to ﬁve randomly picked colonies were tested for
Gram-staining and biochemical characteristics (World Health
Organization [WHO], 1987). All the tested isolates were
identiﬁed as Gram-negative curved/straight rods and V. cholerae
by biochemical tests. One of the representative isolate was sent
to National Institute of Cholera and Enteric Diseases (NICED),
Kolkata for further conﬁrmation and molecular characterization.
The isolate was conﬁrmed as V. cholerae by using the API-
32E (bioMérieux, Marcy l’Etoile, France) and by PCR targeting
the ompW which encodes outer membrane protein-W (Nandi
et al., 2000). By slide agglutination, the isolate (U13533) was
identiﬁed as serogroup O2. Antibiotic susceptibility tests (CLSI,
2014) revealed that the isolate was susceptible to all the tested
antibiotics (Table 1). The urine examination was repeated after
3 days which revealed 2–4 pus cells with no growth in culture.
Oral oﬂoxacin 200 mg was prescribed for 5 days and the patient
was asymptomatic on follow up.
CASE 2
A six and half-year old female child from Howrah, West
Bengal, was admitted to the Tata Medical Center, Kolkata
in April 2013. She had a history of abdominal pain with
occasional vomiting for a month, and rapid respiration for a day.
Examination revealed tachypnoea, an abdominal mass, enlarged
cervical lymph nodes, and features of bilateral pleural eﬀusion.
A diagnosis of Burkitt’s lymphoma was made on the basis of
ﬂow cytometry of pleural ﬂuid as well as marrow morphology
and immunophenotype. Chemotherapy was commenced. She
developed severe respiratory distress requiring ICU admission,
tracheal intubation and mechanical ventilation. She suﬀered
an episode of cardiac arrest following which she developed
features of hypoxic encephalopathy with seizures, decerebrate
posturing and extensor plantar reﬂexes. She became febrile after
3 weeks of ICU admission. Two sets of blood (from central
venous line and peripheral vein) were drawn for bacterial culture
before administering empirical antibiotics, namely cefepime-
tazobactam and teicoplanin. Blood cultures showed uniform
β-hemolytic colonies on blood agar plates. Three suspected
colonies were identiﬁed as V. cholerae using Vitek 2 compact
system (bioMérieux). The bacterial isolate (B748) was sent
to NICED for conﬁrmation. This isolate was conﬁrmed as
V. cholerae by ompW PCR and serotyped as O8. CLSI (2014)
guidelines were followed for antimicrobial susceptibility testing
by disk diﬀusion method. The isolate B748 was susceptible to all
the tested antibiotics (Table 1). Ciproﬂoxacin was added to the
treatment according to the sensitivities obtained. She recovered
from the episode of sepsis, but an MRI scan showed extensive
hypoxic cerebral necrosis. After prolonged discussions with the
family, she was sent home on palliative care, and she died 6 weeks
after her initial presentation.
CASE 3
A 56-years-old lady was admitted to the Sri Ramachandra
Medical College, Chennai, with chills, low blood pressure, and
painful swelling of the right lower leg. She was diagnosed
with diabetic nephropathy with peripheral neuropathy. There
was no fever, diarrhea, nausea, or vomiting reported on
admission. Physical examination revealed hemorrhagic cellulitis
with tenderness in her right leg, but there was no bullous
skin lesion. After admission, two sets of blood samples were
drawn for culture before empiric therapy with parenteral










Ampicillin S S R S
Azithromycin S S S S
Ceftriaxone S S S S
Chloramphenicol S S S S
Ciprofloxacin S S S S
Gentamicin S S S S
Imipenem S S S S
Norfloxacin S S S S
Ofloxacin S S S S
Tetracycline S S S S
Trimethoprime-sulfamethoxazole S S S S
R, resistance; S, susceptible.
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piperacillin tazobactam. Treatment with intravenous ﬂuid
and supportive therapy was initiated. By the morning after
her admission, the patient’s temperature had risen, and
the hemorrhagic cellulitis had rapidly progressed. Emergency
fasciotomy was performed, and parenteral antibiotic therapy
was subsequently changed to imipenem. However, cellulitis
with bullous lesions rapidly progressed in the right leg, in
size and number. After 18 h, respiratory failure developed and
she became deeply confused. She received ﬂuid resuscitation
with vasopressor therapy, intubation and ventilator care for
the septic condition. However, after 24 h of admission, she
died despite aggressive cardiopulmonary resuscitation. Blood
culture results revealed microbial growth after 24 h of incubation
of sample inoculated on 5% sheep blood agar plates. The
colonies evenly exhibited β-hemolysis. Five randomly selected
colonies were oxidase-positive and identiﬁed as Gram-negative
rods by microscopy. Upon subculture, the colonies grew on
thiosulfate-citrate-bile salts-sucrose (TCBS) agar as sucrose
fermenting yellow colonies. It grew in 10% NaCl and was lysine
and ornithine decarboxylase positive and arginine dihydrolase
negative. The isolate was sent to NICED for further conﬁrmation
and other molecular characteristics. API-32E identiﬁcation
(bioMérieux) and the ompW PCR conﬁrmed the isolate
(SRMC-1) as V. cholerae that belonged to serogroup O10. CLSI
(2014) guidelines were followed for antimicrobial susceptibility
testing. The isolate was susceptible in vitro to ﬁrst, second
and third generation cephalosporins; imipenem; gentamicin;
trimethoprim-sulfamethoxazole; tetracycline and ciproﬂoxacin
but resistant to ampicillin (Table 1).
CASE 4
A 72-years-old male with chills and generalized weakness
for 7 days, was admitted to the Global Hospital in Parel,
Mumbai on July, 2013. On the day of admission, the patient’s
temperature peaked to 40◦C with associated chills, nausea, and
dizziness but without diarrhea, vomiting or abdominal pain.
There was no history of malaria, leptospirosis, and dengue.
On examination, the patient was drowsy and dehydrated and
the respiratory system revealed no abnormalities. Blood culture
was made using BACTEC (Becton Dickinson, Sparks, MD,
USA). The contents of the incubated bottle showed bacterial
growth after 12 h. The subcultured colonies uniformly displayed
α-hemolysis on the blood agar plates and were oxidase positive
and Gram-staining revealed small curved Gram-negative bacilli.
API-20E and VITEK2 (bioMérieux) identiﬁcation conﬁrmed the
organism (VC-3) as V. cholerae. The tested isolate at NICED was
positive for ompW and conﬁrmed as serogroup O24. CLSI (2014)
guidelines were followed for antimicrobial susceptibility testing.
The V. cholerae isolate from this case was susceptible to all the
antibiotics (Table 1). Upon recovery, the patient was discharged
after few days of hospitalization.
As shown in Table 2, all the isolates of V. cholerae identiﬁed
in this study harbored potential virulence genes encoding for
hemolysin (hlyA), mannose sensitive hemagglutination (mshA),
and repeat in toxin (rtxA) genes, which might play a role in
the disease process including cytotoxicity and invasion. However,
the other genes encoding for CT, Stn, Chx and structural genes
of T3SS including VcsJ2, VspD, VcsVUQ2, and VcsRTCNSZ
were not detected in the PCR assay (Table 2). Clinicians should
consider V. cholerae non-O1/non-O139 as one of the potential
etiologic agents in cases of invasive infections. Diagnosis of
V. cholerae non-O1/non-O139 from extraintestinal infections
can be a challenging because of its uncommon description
in the literature. Most microbiology laboratories in India
diagnose V. cholerae infection from suspected cases of cholera
or cholera-like diarrhea. Diagnosis of these serogroups can be
conﬁrmed by biochemical identiﬁcation and agglutination with
speciﬁc antisera. However, this process consumes time and there
are no recommended standard methods in the conventional
identiﬁcation.
DISCUSSION
V. cholerae non-O1/non-O139 is ubiquitously present in the
aquatic environments. Infections caused by these vibrios are often
associated with ingestion of contaminated seafood/exposure to
coastal waters. The most common symptoms of infection caused
by this pathogen are mild to moderate gastroenteritis or wound
infections (Lan et al., 2014). These vibrios were also reported
to cause biliary tract infection, primary septicemia, peritonitis,
skin and soft tissue infections, UTI and pneumonia (Sack et al.,
2004; Sangaré et al., 2006; Dutta et al., 2013). In this study,
we found diﬀerent clinical manifestations caused by V. cholerae
non-O1/non-O139 with diverse serogroups.
V. cholerae non-O1/non-O139 are increasingly recognized
as a potential etiologic agent in cases of invasive infections
(CDC, 2014; Chen et al., 2015; Hao et al., 2015). Timely
detection of this pathogen is important in the eﬀective
clinical management. Currently, microbiology laboratories in
India diagnose V. cholerae infection mostly by biochemical
and serological testes. However, antisera speciﬁc for the
TABLE 2 | Phenotype and virulence gene profiling of V. cholerae non-O1/non-O139 isolates.
Isolate Source Serogroup Gene-specific PCR assay results
ompW rtxA mshA hlyA T3SS structure genes stn ctxAB chxA
U13533 Urine O2 + + + + − − − −
B748 Blood O8 + + + + − − − −
SRMC-1 Blood O10 + + + + − − − −
VC-3 Blood O24 + + + + − − − −
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non-O1/non-O139 V. cholerae serogroups are available only
in the reference laboratories. Considering this, the suspected
isolates can be tested for ompW gene that is highly conserved in
V. cholerae (Nandi et al., 2000).
In all the four cases, there was no history of consumption
of seafood or exposure to seawater and hence, the exact
nature of the exposure of patients to V. cholerae remains
unknown. Antibiotics are essential for the proper management
of extraintestinal infections caused by V. cholerae. Currently,
V. cholerae non-O1/non-O139 isolates from many locations
are susceptible to most of the antibiotics like β-lactams,
ﬂuoroquinolones, trimethoprime-sulfamethoxazole, tetracycline,
and chloramphenicol (Sangaré et al., 2006). All the isolates
encountered in this study were susceptible to most of
the antibiotics prescribed in the treatment of extraintestinal
infections and thus the practice can be continued in the treatment
of V. cholerae non-O1/non-O139-mediated infections.
It is well-known that immunocompetent individuals are
vulnerable to several bacterial, viral and parasitic infections.
Although the exact mechanism of pathogenesis of extraintestinal
infection caused by V. cholerae non-O1/non-O139 is not clearly
understood, involvements of multifactorial virulence factors
cannot be ignored (Sack et al., 2004; Hao et al., 2015). Though
the isolates lacked virulence genes encoding for CT, Stn, Chx and
structural genes of T3SS, the potential virulence genes such as
hlyA,mshA, and rtxAwere detected in all the isolates. Association
of these genes in V. cholerae non-O1/non-O139 isolates has been
reported in many ﬁndings (Ottaviani et al., 2011; Dutta et al.,
2013; Khan et al., 2013; Rajpara et al., 2013). Since V. cholerae
non-O1/non-O139 is endemic in many regions, there should be a
standby schema in place for routine screening this organism from
septicemia/UTI cases. This will help clinicians to make a timely
intervention and appropriate management of cases in hospital
settings.
CONCLUSION
Generally, V. cholerae belonging to non-O1/non-O139
serogroups have been considered as an opportunistic pathogen,
which occasionally causes severe disease. Considering increasing
number of reports, appropriate testing and timely interventions
are essential.
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